Samlyn Capital, LLC Novartis Ag Transaction History

Samlyn Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $37 Million - $40.8 Million	-432,678 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $32.6 Million - $40.2 Million	432,678 New	432,678 $39.5 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $16.2 Million - $19.4 Million	-230,308 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $864,488 - $927,953	11,952 Added 5.47%	230,308 $19.3 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $16.2 Million - $16.9 Million	218,356	218,356 $18.7 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.